Mirada works in collaboration with BTG to develop software to support BTG’s portfolio of interventional medicine products, including software solutions to optimize radioembolization therapy. Simplicit90YTM is a customized, easy-to-use dosimetry application that helps physicians to personalize treatment with 90Y therapies for patients with liver cancer.
LEARN MORE ABOUT Simplicit90YTM
